Finance

Lists
CORONA:NSE
Corona Remedies Ltd
₹2 058,00
+1,57%
(+31,80) 1D
14 Okt., 15:30:01 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for CORONA...
Open
₹2 024,00
High
₹2 067,00
Low
₹2 020,10
Mkt. cap
125,87 mjd
Avg. vol.
45,14 k
Volume
9,63 k
Dividend
0,49%
Quarterly dividend
₹2,50
Ex-dividend date
19 Jun. 2026
P/E ratio
63,25
52-wk high
₹2 292,40
52-wk low
₹1 336,60
EPS
₹32,54
No. of employees
5 k
Open
₹2 024,00
High
₹2 067,00
Low
₹2 020,10
Mkt. cap
125,87 mjd
Avg. vol.
45,14 k
Volume
9,63 k
Dividend
0,49%
Quarterly dividend
₹2,50
Ex-dividend date
19 Jun. 2026
P/E ratio
63,25
52-wk high
₹2 292,40
52-wk low
₹1 336,60
EPS
₹32,54
No. of employees
5 k
News stories
From web sources and news partners
About Corona Remedies Ltd
CEO-
Employees5,15 k
Founded2004
Headquarters-
SectorPharmaceutical industry
Websitecoronaremedies.com
Last report
31 Jul. 2026
Fiscal period
Q1 2027
₹9,83 / ₹9,20
+6,85%beat
Revenue / Est. (INR)
4,22 mjd / 4,04 mjd
+4,64%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
3,61 mjd
3,42 mjd
3,53 mjd
4,22 mjd
Cost of goods sold
686,50 m
602,70 m
772,40 m
775,20 m
Cost of revenue
686,50 m
602,70 m
772,40 m
775,20 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,03 mjd
959,40 m
2,14 mjd
1,22 mjd
Operating expense
2,23 mjd
2,08 mjd
2,24 mjd
2,65 mjd
Total operating expenses
2,92 mjd
2,69 mjd
3,01 mjd
3,43 mjd
Operating income
692,70 m
737,10 m
522,70 m
798,90 m
Other non operating income
22,70 m
22,40 m
-58,90 m
31,50 m
EBT including unusual items
697,80 m
552,10 m
547,40 m
803,60 m
EBT excluding unusual items
697,80 m
743,10 m
550,20 m
803,60 m
Income tax expense
174,60 m
139,40 m
94,10 m
202,50 m
Effective tax rate
25,02%
25,25%
17,19%
25,20%
Other operating expenses
1,11 mjd
1,03 mjd
-7,00 m
1,30 mjd
Net income
523,20 m
412,70 m
453,30 m
601,10 m
Net profit margin
14,49%
12,05%
12,84%
14,23%
Earnings per share
-
-
7,41
9,83
Interest and investment income
-
-
70,60 m
-
Interest expense
-19,30 m
-16,60 m
-11,10 m
-26,90 m
Net interest expenses
-19,30 m
-16,60 m
59,50 m
-26,90 m
Depreciation and amortization charges
92,00 m
94,50 m
102,90 m
132,40 m
EBITDA
794,16 m
838,56 m
608,10 m
884,30 m
Gain or loss from assets sale
2,61 m
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme